Synergene Holdings Ltd has been recently joined by Dr Marios Kambouris, a world-leading geneticist with particular specialisation in mapping genes that cause human inherited diseases.

For the past eight years Dr Kambouris was the director of the Molecular Genetics and DNA Diagnostics laboratory at the King Faisal Hospital and Research Center in Riyadh, Saudi Arabia.

He was extensively involved in establishing, performing and interpreting DNA diagnostic testing as well as being involved in the mapping of more than ten novel human genes.

In addition to the mapping of genes for hereditary disorders, Dr Kambouris was also involved in utilisation of populations with unique genetic characteristics for discovery of genes involved in common diseases such as Type 2 Diabetes Mellitus and Cardiovascular disorders.

Dr Kambouris also holds a joint appointment as an adjunct associate professor, at the Department of Genetics, Yale University School of Medicine (New Haven, USA).

He is certified by the American Board of Medical Genetics in Clinical Molecular Genetics as well as Ph.D. Medical Genetics. He holds a Ph.D. in Medical and Molecular Genetics, Indiana University School of Medicine (Indianapolis, USA) as well as a post-doctoral fellowship in Clinical Molecular Genetics and Clinical Genetics at Henry Ford Hospital (Detroit, USA).

Dr Kambouris is, by training, both a molecular geneticist as well as a clinical geneticist with extensive experience in examining, diagnosing, risk assessing, counseling and managing patients with a multitude of genetic disorders.

Dr Kambouris has been employed as the group's global alliance director with responsibility of managing Synergene projects involving alliances with a number of governmental and private organisations in various geographic regions.

Dr Kambouris is also currently working together with Synergene's scientific team to expand the portfolio of services currently offered by the company.